Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
174
-
Total 13F shares, excl. options
-
38,278,856
-
Shares change
-
+213,919
-
Total reported value, excl. options
-
$2,287,865,048
-
Value change
-
+$20,554,967
-
Put/Call ratio
-
31%
-
Number of buys
-
86
-
Number of sells
-
-81
-
Price
-
$59.75
Significant Holders of AERIE PHARMACEUTICALS INC - COM (AERI) as of Q4 2017
219 filings reported holding AERI - AERIE PHARMACEUTICALS INC - COM as of Q4 2017.
AERIE PHARMACEUTICALS INC - COM (AERI) has 174 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38,278,856 shares
.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (5,061,463 shares), Vanguard Group Inc (3,056,143 shares), BlackRock Inc. (2,784,539 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2,611,635 shares), Partner Fund Management, L.P. (2,607,211 shares), Foresite Capital Management III, LLC (1,950,477 shares), Foresite Capital Management II, LLC (1,672,714 shares), JENNISON ASSOCIATES LLC (1,393,373 shares), ORBIMED ADVISORS LLC (1,329,600 shares), and STATE STREET CORP (803,008 shares).
This table shows the top 174 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.